Table 3

Selected sleep stage variables in healthy controls and chronic fatigue syndrome patients who were either less sleepy or sleepier after polysomnography


Healthy
CFS a.m. less sleepya
CFS a.m. sleepiera

Number
26
14
12
Age, years
37 ± 8
39 ± 8
39 ± 8
Body mass index, kg/m2
24.0 ± 4.4
24.1 ± 5.7
25.8 ± 4.7
CES-D score
8 ± 7
20 ± 8b
14 ± 7b,c
Sleep structure



Time in bed, minutes
453 ± 33
433 ± 41
445 ± 44
Total sleep time, minutes
385 ± 38
350 ± 50b
353 ± 61b
Sleep efficiency, percentage
85 ± 8
81 ± 9
79 ± 10b
Number of arousals per hour
8.3 ± 5.2
4.8 ± 3.7
6.7 ± 6.1
Wakefulness, minutes
52 ± 38
64 ± 33
61 ± 35
Stage 1, minutes
45 ± 19
32 ± 12
34 ± 22
Wakefulness plus stage 1, minutes
96 ± 44
96 ± 34
95 ± 37
Stage 2, minutes
222 ± 34
195 ± 29b
202 ± 38
Stage 3, minutes
30 ± 22
50 ± 20b
41 ± 26
Stage 4, minutes
5 ± 11
13 ± 15
7 ± 15
Slow-wave sleep (stage 3 + 4), minutes
35 ± 26
63 ± 30b
48 ± 37
Stage REM, minutes
83 ± 24
60 ± 18b
69 ± 33
Sleep latency, minutes
16 ± 19
20 ± 20
32 ± 31b
REM latency, minutes
107 ± 49
128 ± 64
126 ± 69
Median duration of sleep runs, minutes
15.6 ± 18.4
10.0 ± 6.7
7.9 ± 3.3b
Likert scale (0–15.5)



     Sleepiness



          Evening
6 ± 4
12 ± 2b
6 ± 5c
          Morning
1 ± 2d
7 ± 4b,d
10 ± 2b-d
     Fatigue



          Evening
4 ± 4
11 ± 3b
10 ± 3b
          Morning
1 ± 2d
8 ± 4b,d
11 ± 3b,c
     Pain



          Evening
1 ± 2
8 ± 4b
7 ± 5b
          Morning
0 ± 1
6 ± 4b,d
9 ± 4b,c
     Feeling blue



          Evening
1 ± 2
2 ± 3
1 ± 1
          Morning
0 ± 0d
1 ± 3
1 ± 3

Values are presented as mean ± standard deviation. aData dichotomized based on difference between daytime and nighttime self-reported ratings of sleepiness (P < 0.05, analysis of variance [ANOVA]). bSignificantly different from healthy controls. cSignificantly different from CFS in the a.m. less sleepy group (P < 0.05, ANOVA). dSignificantly different from evening (P < 0.05, paired t test). CES-D, Centers for Epidemiological Study-Depression; CFS, chronic fatigue syndrome; REM, rapid eye movement.

Togo et al. Arthritis Research & Therapy 2008 10:R56   doi:10.1186/ar2425

Open Data